Casdin Capital, LLC Relay Therapeutics, Inc. Transaction History
Casdin Capital, LLC
- $1.16 Billion
- Q2 2024
A detailed history of Casdin Capital, LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 8,448,574 shares of RLAY stock, worth $49.8 Million. This represents 4.75% of its overall portfolio holdings.
Number of Shares
8,448,574
Previous 8,448,574
-0.0%
Holding current value
$49.8 Million
Previous $55.1 Million
-0.0%
% of portfolio
4.75%
Previous 4.77%
Shares
13 transactions
Others Institutions Holding RLAY
# of Institutions
180Shares Held
127MCall Options Held
1.7KPut Options Held
18K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$165 Million1.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$69.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$62.2 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V86.38MShares$37.6 Million0.7% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.04MShares$29.7 Million0.0% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $709M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...